Clinical Trial Update: Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a donor umbilical cord blood transplant regimen using cyclophosphamide, fludarabine phosphate, and total-body irradiati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Cancer Research UK | Conditions: Hematopoietic/Lymphoid Cancer | Phase 2 | Status: UNKNOWN